Item s under Sections 1 and 3 through 8 are not applicable and therefore omitted.

ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

Urologix, Inc. (the “Company”) hereby furnishes a press release, issued on October 24, 2007, disclosing material non-public information regarding its results of operations for the quarter ended September 30, 2007. Also furnished with this Form 8-K as Exhibit 99.2 are certain remarks of the Company’s Chief Financial Officer, Elissa J. Lindsoe, and the Company’s Senior Vice President and General Manager, Kirsten Doerfert, made at a related telephone conference held on October 25, 2007.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

 

Exhibit No.  

Description

99.1   Press Release issued on October 24, 2007.
99.2   Certain remarks of Elissa J. Lindsoe and Kirsten Doerfert at a teleconference held on October 25, 2007.

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

UROLOGIX, INC.

By:

 

/s/ Fred B. Parks

  Fred B. Parks
  Chief Executive Officer

Date: October 25, 2007